272 related articles for article (PubMed ID: 10555694)
1. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
[TBL] [Abstract][Full Text] [Related]
3. Antibody-coated suture enhances immune response: important ideas emerge from multidisciplinary training.
Whiteside TL
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1237-8. PubMed ID: 10555695
[No Abstract] [Full Text] [Related]
4. Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.
Shibuya TY; Kim S; Nguyen K; Parikh P; Wadhwa A; Brockardt C; Do J
Laryngoscope; 2003 Nov; 113(11):1870-84. PubMed ID: 14603040
[TBL] [Abstract][Full Text] [Related]
5. T cell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production.
Jeurink PV; Vissers YM; Rappard B; Savelkoul HF
Cryobiology; 2008 Oct; 57(2):91-103. PubMed ID: 18593572
[TBL] [Abstract][Full Text] [Related]
6. Bioactive suture: a novel immunotherapy for head and neck cancer.
Shibuya TY; Kim S; Nguyen K; Do J; McLaren CE; Li KT; Chen WP; Parikh P; Wadhwa A; Zi X; Chen VY; Wong HS; Armstrong WB; Yoo GH
Clin Cancer Res; 2004 Oct; 10(20):7088-99. PubMed ID: 15501989
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction of regulatory T cells by anti-CD3 antibody in humans.
Abraham M; Karni A; Dembinsky A; Miller A; Gandhi R; Anderson D; Weiner HL
J Autoimmun; 2008; 30(1-2):21-8. PubMed ID: 18191540
[TBL] [Abstract][Full Text] [Related]
8. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.
Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP
J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696
[TBL] [Abstract][Full Text] [Related]
9. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.
Harada M; Okamoto T; Omoto K; Tamada K; Takenoyama M; Hirashima C; Ito O; Kimura G; Nomoto K
Immunology; 1996 Mar; 87(3):447-53. PubMed ID: 8778032
[TBL] [Abstract][Full Text] [Related]
10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
11. Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation.
Arrington JL; Chapkin RS; Switzer KC; Morris JS; McMurray DN
Clin Exp Immunol; 2001 Sep; 125(3):499-507. PubMed ID: 11531960
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of poor CD3 response in head and neck cancer.
Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
[TBL] [Abstract][Full Text] [Related]
13. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
14. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
[TBL] [Abstract][Full Text] [Related]
15. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
16. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.
Li Q; Yu B; Grover AC; Zeng X; Chang AE
J Immunother; 2002; 25(4):304-13. PubMed ID: 12142553
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
19. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
[TBL] [Abstract][Full Text] [Related]
20. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
